Bilim ve AraştırmaAI Revolutionizes Drug Discovery and Healthcare Investment
Artificial intelligence technologies are revolutionizing drug development processes by shortening timelines and reducing costs. This transformation is reshaping the financial dynamics of the healthcare sector, from the valuation of biotechnology companies to investor strategies. Advances in statistical modeling and data analysis are paving the way for new drug discoveries.






















